regulatory approval

Warner Bros. rejected Paramount's $31/share bid, setting February 23 deadline for Skydance's final offer. Company prefers Netflix deal at $27.75/share with matching rights.

Human microbiome market expected to grow nearly fourfold to $3.27B by 2035, driven by advancing sequencing technology and 215+ therapeutic candidates in clinical development.

Enstar Group agrees to acquire AF Group from Blue Cross Blue Shield of Michigan for $3.3 billion in gross written premium, expanding its property and casualty insurance portfolio nationwide.